High-flow Oxygen for Vaso-occlusive Pain Crisis

NCT03976180 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

350

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DEVICE: Stadard low-flow oxygen
DEVICE: HFNO with low FiO2 (21%-30%)
DEVICE: HFNO with intermediate FiO2 (50%)
DEVICE: HFNO with high FiO2 (100%)

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]